Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 72162-2367

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 72162-2367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rabe-str (Rabe Str)

Chemical structure of Rabeprazole Sodium, showing its molecular arrangement including a benzimidazole ring and a methoxyethoxy side chain.*

FDA Label Image

Rabe-str2 (Rabe Str2)

A line graph showing mean heartburn scores over a 28-day study period for three groups: placebo, Rabeprazole 10 mg, and Rabeprazole 20 mg. The x-axis represents study days, with baseline to day 28, and the y-axis shows mean heartburn score from 0 (none) to 4 (very severe). Scores decrease notably after day 0, especially for Rabeprazole 20 mg.*

FDA Label Image

Rabe-str3 (Rabe Str3)

A line graph showing mean heartburn scores over a 28-day study period. The x-axis represents study days from -14 to 28, and the y-axis shows mean heartburn scores from 0 (None) to 4 (Very Severe). Two lines compare placebo (dashed) and Rabeprazole 20 mg (solid), with heartburn scores decreasing after study day 0 for the Rabeprazole group.*

FDA Label Image

Rabe-str4 (Rabe Str4)

A line graph comparing mean heartburn scores over 28 study days between a placebo group and a group treated with Rabeprazole Sodium 20 mg. The x-axis shows study days from -14 to 28, and the y-axis shows mean heartburn scores from 0 (none) to 4 (very severe). Two lines represent scores for placebo (dashed) and Rabeprazole 20 mg (solid), indicating lower mean scores with Rabeprazole treatment over the study period.*

FDA Label Image

Label (Lbl721622367)

Label for Rabeprazole Sodium Delayed-Release Tablets USP, 20 mg. The package contains 500 tablets and is labeled Rx only. The label shows repackaging by Bryant Ranch Prepack, Inc., Burbank, CA, and manufacturing by Alkem Laboratories Ltd. Storage and dispensing instructions and a barcode are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.